𝔖 Bobbio Scriptorium

✦ LIBER ✦

Long-term Outcomes After Bladder Preserving Combined Modality Therapy for Muscle-invasive Bladder Cancer: A Pooled Analysis of RTOG 8802, 8903, 9506, 9706, 9906, and 0233

✍ Scribed by Mak, R.H.; Hunt, D.; Shipley, W.U.; Efstathiou, J.A.; Yan, Y.; Tester, W.J.; Hagan, M.P.; Kaufman, D.S.; Heney, N.M.; Zietman, A.L.

Book ID: 122891516
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 53 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.214

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bladder Preservation Therapy for Muscle-

Bladder Preservation Therapy for Muscle-Invading Bladder Cancers (MIBC): Long-term Clinical Outcomes from RTOG 8802, 8903, 9506, and 9706 and Molecular Correlates along the VEGF Pathway

✍ A. Chakravarti; J. James; J. Efstathiou; C. Wu; A. Klimowicz; H. Sandler; T. Lau 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Reply to Neeraj Kumar Goyal, Manish Garg

Reply to Neeraj Kumar Goyal, Manish Garg, and Apul Goel's Letter to the Editor re: Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol 2012;61:705–11

✍ Jason A. Efstathiou; William U. Shipley; Anthony L. Zietman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB